search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
WIDE REACH, BIG PAYOFF


“We think there’s a good overlap between the kinds of companies we’re working with


and Department of Defense needs regarding traumatic brain injury, post-traumatic stress and the optimization of human performance.


“We’re looking for companies that have a significantly better solution to an impor- tant problem, who then go on to lead that category.”


A NEW VENTURE Te USAMRDC partnership with venture capital companies is still a burgeoning effort—the pairing with ARCH is less than a year old—but on a larger scale, it represents the command’s desire to quickly find, fund and procure the types of tech- nologies required to keep U.S. Soldiers safe on the seemingly ever-changing battlefield of the future; a place defined as much by potential location as by the technology (and the technological knowhow) of a given adversary. Such corporate efforts are chiefly routed through the Medical Tech- nology Enterprise Consortium (MTEC), a powerful USAMRDC partner that aims to accelerate the development of revolu- tionary medical solutions to meet the needs of U.S. military personnel and veter- ans. In a unique way—and in an almost parallel manner—MTEC has a reach that rivals ARCH’s own.


For Jill Sorensen, the chief operating offi- cer for MTEC, focusing on such a vast array of military medical requirements, especially in an era of fast-moving techno- logical landscapes, requires near-constant, round-the-clock attention. “We’re living in the realm of the unmet medical need, [and] so the question is—how do we accel- erate filling that gap?” said Sorensen,





noting the contemporary need to identify both immediate and potential medical concerns, and their accompanying solu- tions, as quickly as possible. “A term that we’ve been using to explain this is ‘read- iness,’ or in this context, ‘commercial readiness.’ ”


SHARED VISION Tat MTEC’s own priorities would align so cleanly with the USAMRDC’s (i.e., a keen focus on Soldier readiness) is to be expected. A nonprofit corporation


comprising a vast


stable of private,


academic and not-for-profit organiza- tions, MTEC is a 501(c)(3) biomedical technology consortium collaborating with USAMRDC under an other-transaction authority agreement, a mechanism that allows consortium members and govern- ment program managers to hold open discussions throughout the solicitation phase. Tat capability, in turn, enables the rapid exchange of information among government entities, private technology developers and funding partners, which ultimately facilitates partnerships and paves the way for innovation. At the end of 2020, MTEC boasted a roster of more than 460 such members. Simply put, once they get their hands around a prototype- ready innovation, MTEC members have the connections required to bring that product to market.


What makes this partnership so unique, however, is the manner in which these


IN DEPTH


Medical personnel from Regional Health Command – Pacific use virtual health capabilities to treat a simulated patient during Joint Warfighting Assessment April 23 to May 10 in Yakima, Washington. ARCH provides more in-depth examinations of those chosen technologies for USAMRDC leaders. (Photo by Flavia Hulsey, Regional Health Command – Pacific)


14


Army AL&T Magazine


Spring 2021


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120